Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia

NCT02570152 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02570152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02570152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia
Lead sponsor
GlaxoSmithKline
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2016
Completion date
June 28, 2019
Enrollment
2,004 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dengue